CL2019000410A1 - Método para prevenir o tratar la pérdida de la audición. - Google Patents

Método para prevenir o tratar la pérdida de la audición.

Info

Publication number
CL2019000410A1
CL2019000410A1 CL2019000410A CL2019000410A CL2019000410A1 CL 2019000410 A1 CL2019000410 A1 CL 2019000410A1 CL 2019000410 A CL2019000410 A CL 2019000410A CL 2019000410 A CL2019000410 A CL 2019000410A CL 2019000410 A1 CL2019000410 A1 CL 2019000410A1
Authority
CL
Chile
Prior art keywords
prevent
hearing loss
treat hearing
treat
methods
Prior art date
Application number
CL2019000410A
Other languages
English (en)
Inventor
Alexander Bausch
Original Assignee
Support Venture Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Support Venture Gmbh filed Critical Support Venture Gmbh
Publication of CL2019000410A1 publication Critical patent/CL2019000410A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCIÓN SE RELACIONA CON MÉTODOS PARA PREVENIR O TRATAR LA PÉRDIDA DE AUDICIÓN Y MÉTODOS PARA PREVENIR O INHIBIR LA DEGENERACIÓN DE CÉLULAS CILIADAS O LA MUERTE DE CÉLULAS CILIADAS EN UN SUJETO.
CL2019000410A 2016-08-17 2019-02-14 Método para prevenir o tratar la pérdida de la audición. CL2019000410A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16184541 2016-08-17

Publications (1)

Publication Number Publication Date
CL2019000410A1 true CL2019000410A1 (es) 2019-06-28

Family

ID=56740115

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019000410A CL2019000410A1 (es) 2016-08-17 2019-02-14 Método para prevenir o tratar la pérdida de la audición.

Country Status (18)

Country Link
US (1) US20190209568A1 (es)
EP (1) EP3500258A1 (es)
JP (1) JP2019528273A (es)
KR (1) KR20190039142A (es)
CN (1) CN109562105A (es)
AU (1) AU2017313296A1 (es)
BR (1) BR112019003006A2 (es)
CA (1) CA3033887A1 (es)
CL (1) CL2019000410A1 (es)
CO (1) CO2019001402A2 (es)
EA (1) EA201990220A1 (es)
IL (1) IL264625A (es)
MA (1) MA45981A (es)
MX (1) MX2019001819A (es)
PE (1) PE20190421A1 (es)
PH (1) PH12019550015A1 (es)
SG (1) SG11201900776TA (es)
WO (1) WO2018033543A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021524493A (ja) * 2018-07-13 2021-09-13 キナラス アーゲー 線維性疾患を予防または処置するためのＰＰＡＲアゴニストおよびｐ３８キナーゼ阻害剤の組合せ物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US5421818A (en) 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
TWI249401B (en) * 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
US20020151491A1 (en) * 2000-11-28 2002-10-17 Jian-Dong Li Composition and method for treating the over-production of mucin in diseases such as otitis media using an inhibitor of MUC5AC
BRPI0207172B8 (pt) * 2001-02-12 2021-05-25 Hoffmann La Roche pirido-pirimidinas 6-substituída, sua composição e seu uso, bem como seu intermediário
ES2281843T3 (es) 2003-11-13 2007-10-01 F. Hoffmann-La Roche Ag Pirido-7-pirimidin-7-onas sustituidas con hidroxialquilo.
US8870826B2 (en) 2004-05-24 2014-10-28 Auris Medical Llc Combined otic aspirator and medication dispenser
EP2158182A2 (en) 2007-06-15 2010-03-03 F. Hoffmann-Roche AG A novel process for the preparation of 3-amino-pentan-1,5-diol
CA2975566A1 (en) * 2015-02-11 2016-08-18 Support-Venture Gmbh Method of preventing or treating hearing loss
HUE053648T2 (hu) * 2016-06-08 2021-07-28 Support Venture Gmbh Gyógyászati kombinációk rák kezelésére

Also Published As

Publication number Publication date
EA201990220A1 (ru) 2019-08-30
CN109562105A (zh) 2019-04-02
JP2019528273A (ja) 2019-10-10
PE20190421A1 (es) 2019-03-19
AU2017313296A1 (en) 2019-02-14
US20190209568A1 (en) 2019-07-11
MX2019001819A (es) 2019-06-13
CO2019001402A2 (es) 2019-02-19
KR20190039142A (ko) 2019-04-10
BR112019003006A2 (pt) 2019-05-14
MA45981A (fr) 2019-06-26
EP3500258A1 (en) 2019-06-26
PH12019550015A1 (en) 2019-07-24
CA3033887A1 (en) 2018-02-22
WO2018033543A1 (en) 2018-02-22
IL264625A (en) 2019-02-28
SG11201900776TA (en) 2019-03-28

Similar Documents

Publication Publication Date Title
CL2017002021A1 (es) Método para prevenir o tratar la pérdida de la audición.
BR112019006160A2 (pt) composições e métodos para o tratamento das condições oftálmicas
AU201616882S (en) Headphone
BR112017022391A2 (pt) composições e métodos para a fiscalização de câncer de próstata
CL2018001788A1 (es) Composiciones y métodos para evaluar el riesgo de ocurrencia de cáncer.
CL2019000410A1 (es) Método para prevenir o tratar la pérdida de la audición.
ES1158062Y (es) Util para extraccion e insercion de cojinetes casquillos y similares
AU356666S (en) Hearing device retainer
AU201712717S (en) Valve
CL2018000123A1 (es) Criopreservación de embriones de ungulados
ES1155535Y (es) Cortadora de citricos o similares en rodajas
AU367007S (en) Footwear
AU366852S (en) Footwear
AU201612758S (en) Jumpstarter
AU356746S (en) Key retainer
TH1601001707B (th) วิธีการและชุดเครื่องขยายความกว้างแถบความถี่
AU359586S (en) Footwear
AU359589S (en) Footwear
AU359588S (en) Footwear
AU359585S (en) Footwear
AU359587S (en) Footwear
AU361081S (en) Keyring
AU361082S (en) Keyring
AU357541S (en) An escutcheon
AU357543S (en) An escutcheon